Design and optimization of pellets formulation containing curcumin ascorbic acid co-amorphous mixture for ulcerative colitis management
- 24 November 2020
- journal article
- research article
- Published by Taylor & Francis in Particulate Science and Technology
- Vol. 39 (7) , 859-867
Abstract
Curcumin is known for its various therapeutic properties like anti-inflammatory, antioxidant, anticancer, however, its oral use is restricted due to its low solubility and dissolution rate in alkaline pH. In this study co-amorphous mixture of curcumin–ascorbic acid (CU:AA) of different molar ratios was prepared using the ball milling method. The solubility and characterization of the mixture were studied using FTIR, DSC, and XRD study. Mixture (1:0.50) molar ratio showed the highest solubility and was formulated in pellets dosage and optimized using 32 full factorial designs. The solubility results revealed that a significant increase (p < 0.005) in the solubility of curcumin by the ratio 1:0.50 (212 ± 12 µg/ml) compared to the pure drug (90.0 ± 10 µg/ml). XRD and DSC studies confirmed the formation of amorphous curcumin, whereas FTIR elucidated weak hydrogen interactions. In-vitro dissolution study results showed the (CU:AA) ratio (1:0.50) higher percent drug release (81.61 ± 5.12%) compared to the pure drug (19.44 ± 4.60%). The developed formulations are found to be stable. Therefore, the prepared pellets of co-amorphous mixture enhance the solubility, dissolution rate, and stability of curcumin in higher pH, which will become a promising approach for combination therapy in the treatment of ulcerative colitis patients.Keywords
This publication has 48 references indexed in Scilit:
- Water soluble complexes of curcumin with cyclodextrins: Characterization by FT-Raman spectroscopyVibrational Spectroscopy, 2012
- Guar Gum, Xanthan Gum, and HPMC Can Define Release Mechanisms and Sustain Release of Propranolol HydrochlorideAAPS PharmSciTech, 2010
- Formulation Design and Optimization of Novel Taste Masked Mouth-Dissolving Tablets of Tramadol Having Adequate Mechanical StrengthAAPS PharmSciTech, 2009
- Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compoundJournal of Pharmaceutical and Biomedical Analysis, 2008
- Sintering of wax for controlling release from pelletsAAPS PharmSciTech, 2007
- Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapyJournal of Nanobiotechnology, 2007
- Curcumin Therapy in Inflammatory Bowel Disease: A Pilot StudyDigestive Diseases and Sciences, 2005
- Curcumin: A natural antiinflammatory agentIndian Journal of Pharmacology, 2005
- Extrusion/Spheronization2003
- Release of Pentoxifylline from Xanthan Gum Matrix TabletsDrug Development and Industrial Pharmacy, 2003